Option Care Health, Inc. (OPCH): Price and Financial Metrics


Option Care Health, Inc. (OPCH): $21.29

0.92 (+4.52%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

OPCH POWR Grades


  • Growth is the dimension where OPCH ranks best; there it ranks ahead of 95.07% of US stocks.
  • OPCH's strongest trending metric is Growth; it's been moving down over the last 31 weeks.
  • OPCH ranks lowest in Quality; there it ranks in the 34th percentile.

OPCH Stock Summary

  • OPCH's current price/earnings ratio is 414.65, which is higher than 97.92% of US stocks with positive earnings.
  • In terms of twelve month growth in earnings before interest and taxes, Option Care Health Inc is reporting a growth rate of 1,630.58%; that's higher than 98.65% of US stocks.
  • As for revenue growth, note that OPCH's revenue has grown 38.18% over the past 12 months; that beats the revenue growth of 85.96% of US companies in our set.
  • If you're looking for stocks that are quantitatively similar to Option Care Health Inc, a group of peers worth examining would be FLL, MAGS, ARCE, SYPR, and KOF.
  • OPCH's SEC filings can be seen here. And to visit Option Care Health Inc's official web site, go to www.optioncarehealth.com.

OPCH Valuation Summary

  • OPCH's price/sales ratio is 1.2; this is 89.87% lower than that of the median Healthcare stock.
  • OPCH's EV/EBIT ratio has moved down 102 over the prior 243 months.
  • Over the past 243 months, OPCH's price/sales ratio has gone up 0.7.

Below are key valuation metrics over time for OPCH.

Stock Date P/S P/B P/E EV/EBIT
OPCH 2020-01-13 2.4 3.1 -30.7 -336.8
OPCH 2018-07-11 0.5 -4.0 -6.0 -87.2
OPCH 2018-05-15 0.4 -3.1 -4.6 -77.7
OPCH 2013-12-16 0.6 1.2 -10.1 -44.8
OPCH 2011-05-13 0.2 1.9 -6.4 28.6
OPCH 2006-07-10 0.2 1.1 -7.8 -6.9

OPCH Growth Metrics

  • Its 4 year cash and equivalents growth rate is now at 859.43%.
  • Its 2 year price growth rate is now at 20.88%.
  • The 3 year price growth rate now stands at -25.56%.
OPCH's revenue has moved up $775,990,000 over the prior 15 months.

The table below shows OPCH's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-03-31 3,086.407 127.369 8.973
2020-12-31 3,032.61 127.392 -8.076
2020-09-30 2,948.676 124.625 -41.726
2020-06-30 2,782.947 96.78 -86.183
2020-03-31 2,233.616 64.479 -97.249
2019-12-31 2,310.417 39.467 -75.92

OPCH Price Target

For more insight on analysts targets of OPCH, see our OPCH price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $23.64 Average Broker Recommendation 1.33 (Strong Buy)

OPCH Stock Price Chart Interactive Chart >

Price chart for OPCH

OPCH Price/Volume Stats

Current price $21.29 52-week high $22.69
Prev. close $20.37 52-week low $10.52
Day low $20.64 Volume 1,939,600
Day high $21.75 Avg. volume 1,132,303
50-day MA $20.68 Dividend yield N/A
200-day MA $18.22 Market Cap 3.83B

Option Care Health, Inc. (OPCH) Company Bio


Option Care Health, Inc. provides infusion and home care management solutions. The Company offers products, services, and condition-specific clinical management programs for gastrointestinal abnormalities, infectious diseases, cancer, organ and blood cell transplants, bleeding disorders, and heart failures. Option Care Health serves patients in the United States.


OPCH Latest News Stream


Event/Time News Detail
Loading, please wait...

OPCH Latest Social Stream


Loading social stream, please wait...

View Full OPCH Social Stream

Latest OPCH News From Around the Web

Below are the latest news stories about Option Care Health Inc that investors may wish to consider to help them evaluate OPCH as an investment opportunity.

Option Care Health names Seema Kumbhat as chief medical officer

Option Care Health (OPCH) announces the appointment of Seema Kumbhat as the company's chief medical officer.In the newly created role, Kumbhat will oversee all clinical strategies for the company, including clinical operations, continuous quality improvement, accreditation, clinically related sales and marketing efforts, and adherence to regulatory requirements.Prior to joining Option Care Health, she served as Senior...

Seeking Alpha | July 28, 2021

Option Care Health Appoints Dr. Seema Kumbhat to the Position of Chief Medical Officer

BANNOCKBURN, Ill., July 28, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”)(Nasdaq: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced today that Dr. Seema Kumbhat has joined the Company as Chief Medical Officer. In this newly created role, Dr. Kumbhat will oversee all clinical strategies for the Company, including clinical operations, continuous quality improvement, accreditation, clinically related

Yahoo | July 28, 2021

Option Care (OPCH) Reports Next Week: Wall Street Expects Earnings Growth

Option Care (OPCH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 27, 2021

AlayaCare and Option Care Health Announce Joint Technology Collaboration Agreement

MONTREAL and BANNOCKBURN, Ill., July 21, 2021 (GLOBE NEWSWIRE) -- AlayaCare, a global home and community care software company, and Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the largest independent provider of home and alternate site infusion services in the United States, announced today that they have formally established a technology collaboration to develop innovative software for alternate site infusion therapy. This co-development effort builds upon the companies’ exi

Yahoo | July 21, 2021

Is Option Care Health, Inc.'s (NASDAQ:OPCH) ROE Of 0.9% Concerning?

Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...

Yahoo | July 19, 2021

Read More 'OPCH' Stories Here

OPCH Price Returns

1-mo N/A
3-mo 20.83%
6-mo 7.04%
1-year 74.08%
3-year 97.86%
5-year 100.09%
YTD 36.13%
2020 4.83%
2019 4.48%
2018 22.68%
2017 179.81%
2016 -40.57%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6908 seconds.